Login / Signup

Weight loss and cardiovascular disease risk outcomes of semaglutide: a one-year multicentered study.

Wissam GhusnSima FansaDiego AnazcoElif TamaBryan NicolaldeKhushboo GalaAlan De la RosaDaniel SacotoLizeth CifuentesAlejandro CamposFauzi FeresMaria Daniela Hurtado AAndres Acosta
Published in: International journal of obesity (2005) (2024)
Semaglutide demonstrated notable improvement in obesity, metabolic, and cardiovascular disease risk outcomes in a clinical setting.
Keyphrases
  • cardiovascular disease
  • weight loss
  • type diabetes
  • bariatric surgery
  • insulin resistance
  • roux en y gastric bypass
  • cardiovascular risk factors
  • cardiovascular events
  • adipose tissue
  • body mass index